EUVIMEDEUVIMED entdecken
Übersichtsarbeit

From Genomic Alterations to Functional Tumor Biology: Integrating Organoids and Organ‐on‐a‐Chip in Colorectal Cancer

Woei-Yau Kao iD, Lu-Kai Wang iD, Fu-Ming Tsai iD

Biology of the Cell · 2026-06 · 118 (6)

DOI: 10.1111/boc.70072 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biology of the Cell, online erschienen am 24.06.2026. Verfasst von Woei-Yau Kao und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology‑Oncology, Department of Medicine, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei City, Taiwan. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Organoids, Genomics, Lab-On-A-Chip Devices. Die Arbeit nennt 107 Literaturangaben. Gefördert von: Taipei Tzu Chi Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Colorectal cancer (CRC) develops through the stepwise accumulation of genetic alterations, including mutations in APC , KRAS , and TP53 , which drive tumor initiation and progression. Although advances in genomic profiling have significantly improved our understanding of CRC, translating these alterations into functional outcomes and therapeutic responses remains a major challenge. This limitation arises from tumor heterogeneity, context‐dependent signaling, and the dynamic nature of tumor evolution. Recent advances in patient‐derived organoids (PDOs) have provided a platform that preserves tumor‐specific architecture and genetic features, enabling functional interrogation of drug responses. However, PDOs lack critical components of the tumor microenvironment, such as stromal, immune, and mechanical cues. Organ‐on‐a‐chip (OoC) technologies, particularly organoid‐on‐a‐chip systems in which PDOs are integrated into microfluidic devices, further address these limitations by recapitulating physiological conditions and multicellular interactions. In this review, we discuss the genetic evolution of CRC and highlight how emerging functional models, including PDOs and organoid‐on‐a‐chip platforms, bridge the gap between genomic alterations and tumor behavior. We propose that integrating these platforms offers a promising framework for advancing functional precision medicine and improving our understanding of CRC biology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsOrganoidsGenomicsLab-On-A-Chip DevicesHumansAnimalsMicrophysiological SystemsTumor MicroenvironmentMutation

Stichwörter der Autor:innen

APCKRASTP53colorectal cancerorganoid‐on‐a‐chippatient‐derived organoidsprecision medicine

Autor:innen und Institutionen

  • Division of Hematology‑Oncology, Department of Medicine, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei City, Taiwan.
  • School of Medicine, Tzu Chi University, Hualien, Taiwan.
  • National Center for Biomodels, National Institutes of Applied Research, Taipei, Taiwan.
  • Department of Research, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei City, Taiwan.

ORCID-Profile: Woei-Yau Kao, Lu-Kai Wang, Fu-Ming Tsai

Förderung

  • Taipei Tzu Chi Hospital

Zitieren

APA

Kao, W. Y., Wang, L. K., & Tsai, F. M. (2026). From Genomic Alterations to Functional Tumor Biology: Integrating Organoids and Organ‐on‐a‐Chip in Colorectal Cancer. Biology of the Cell, 118(6). https://doi.org/10.1111/boc.70072

Vancouver

Kao WY, Wang LK, Tsai FM. From Genomic Alterations to Functional Tumor Biology: Integrating Organoids and Organ‐on‐a‐Chip in Colorectal Cancer. Biology of the Cell. 2026;118(6). doi:10.1111/boc.70072

BibTeX
@article{Kao2026,
  author = {Kao, Woei-Yau and Wang, Lu-Kai and Tsai, Fu-Ming},
  title = {From Genomic Alterations to Functional Tumor Biology: Integrating Organoids and Organ‐on‐a‐Chip in Colorectal Cancer},
  journal = {Biology of the Cell},
  year = {2026},
  volume = {118},
  number = {6},
  doi = {10.1111/boc.70072}
}
Kostenlos starten →